NCT02004028 2024-02-20
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
Verastem, Inc.
Phase 2 Terminated
Verastem, Inc.
Colotech A/S
GI View Ltd.
Universitätsklinikum Hamburg-Eppendorf
Texas Tech University Health Sciences Center, El Paso
Assistance Publique - HĂ´pitaux de Paris
Assistance Publique - HĂ´pitaux de Paris